Good things happen when you narrow your focus
Welcome to Conference

Write us on info@evently.com

Follow Us

Image Alt
  /  Krystian Jażdżewski

Krystian Jażdżewski

Professor of medicine, geneticist, endocrinologist, head of Department of Genomic Medicine at Medical University of Warsaw and the Laboratory of Human Cancer Genetics at University of Warsaw. Co-founder of Warsaw Genomics, a diagnostic company which creates unique genomic tests that allow for personalized anti-cancer prophylaxis. In his research performed in USA and Poland he focused on identifying the molecular changes underlying heritability and pathogenesis of human cancers. He published several research papers with more than 3000 citations. He developed the proprietary method of genetic analysis, which decreased 20-fold the price of the multigene test. Due to this innovation he was able to start the National Cancer Risk Screening Program, which attracted over 50 000 people in the first year. The aim of the Program is to identify all the people predisposed to inherited cancers in entire Polish population, and introduce each person at risk into personalized prophylactic plan. He was honored by the National Award for Vision and Innovation by the Polish Business Roundtable (2017), Man of the Year in Science and Innovation Award by Readers of “Gazeta Wyborcza” Daily, and One of the Most Influential People in Polish Medicine Award by “Puls Medycyny” Weekly.

Website

All Sessions By Krystian Jażdżewski

Post-genomic society
Masters&Robots / Day 1 15:50
Decoding the first human genome took thirteen years and cost more than three billion dollars. Today, it is available to everyone, takes three days, and costs less than two thousand dollars. As a result, in recent years our society has been flooded with genomic data. Every genetic test generates an enormous amount of data about our body. We discover serious disorders even before we start to feel that something is wrong. We can predict cancer and the specific type most likely to develop, as well as forecast which drugs will be most helpful and which may kill the patient. Based on personalized genomic data, prevention is more effective than ever in the history of medicine. However, these rapid advancements create challenges which we need to urgently address. Open-source, freely available big-data analysis engines are easily accessible to everyone. International genomic databases provide the most up-to-date knowledge. How do tests on-demand and on-line biological interpretation, performed outside the doctor’s office, change our society and medicine? Is it possible for the medical world to shift from treatment-based to prevention-based medicine – and how do we approach this challenge? Our diagnostic capacities are limited and currently do not allow us to make the most of the potential of modern genomic medicine. There is not enough equipment – not enough MRI or CT scanners, not enough doctors to consult us. Are we, as patients, ready to know the list of diseases to which we are susceptible, diseases which await us in the course of our lives? Some of them are preventable, but some are not – are we ready to hear bad news? And how are we to deal with the risk prediction of, say, 70% or 85%? At Masters & Robots, Professor Krystian Jażdżewski will talk about the genomic revolution and the scientific, social, and moral challenges involved. He will discuss the National Cancer Risk Screening Program – the first nation-wide initiative aiming to identify all people predisposed to inherited cancers and to equip them with a personalized preventive plan.